IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against PTC Therapeutics, Inc. And Encourages Investors With Losses To Contact the Firm

LOS ANGELES--()--Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against PTC Therapeutics, Inc. (“PTC” or the “Company”) (Nasdaq:PTCT). Investors who purchased or otherwise acquired shares between May 6, 2014 and February 23, 2016, inclusive (the “Class Period”), should contact the firm no later than 60 days from the date of this notice.

If you are a shareholder who suffered a loss during the Class Period, click here to participate. In addition, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 708, Marina Del Rey, CA 90292, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the complaint, the Company failed to disclose that the NDA submitted to the FDA for Translarna was not complete enough to allow a substantive review of the application.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Goldberg Law PC, Los Angeles
Michael Goldberg, Esq., 800-977-7401
Brian Schall, Esq., 800-977-7401
info@goldberglawpc.com

Contacts

Goldberg Law PC, Los Angeles
Michael Goldberg, Esq., 800-977-7401
Brian Schall, Esq., 800-977-7401
info@goldberglawpc.com